MEETINGS - Biological Safety Assessment of Medical Devices (Germany) December 1997:
This article was originally published in Clinica
Biological Safety Assessment of Medical Devices is the subject of a conference to be held on December 3-4 in Munich, Germany. The meeting will address issues such as new developments associated with the Medical Devices Directive, risk analysis, material characterisation, degradation products, biological testing and vigilance reporting. For more information contact Dr Ann Walford in the UK. Tel: +44 171 404 3040. Fax: +44 171 404 2081.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.